Cargando…

Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients

BACKGROUND: Data regarding long‐term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long‐term outcome and prognostic factors in a large cohort of thromboangiitis obliterans. METHODS AND RESULTS: Retrospective multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Joncour, Alexandre, Soudet, Simon, Dupont, Axelle, Espitia, Olivier, Koskas, Fabien, Cluzel, Philippe, Hatron, Pierre Yves, Emmerich, Joseph, Cacoub, Patrice, Resche‐Rigon, Matthieu, Lambert, Marc, Saadoun, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405548/
https://www.ncbi.nlm.nih.gov/pubmed/30571594
http://dx.doi.org/10.1161/JAHA.118.010677
_version_ 1783401094603341824
author Le Joncour, Alexandre
Soudet, Simon
Dupont, Axelle
Espitia, Olivier
Koskas, Fabien
Cluzel, Philippe
Hatron, Pierre Yves
Emmerich, Joseph
Cacoub, Patrice
Resche‐Rigon, Matthieu
Lambert, Marc
Saadoun, David
author_facet Le Joncour, Alexandre
Soudet, Simon
Dupont, Axelle
Espitia, Olivier
Koskas, Fabien
Cluzel, Philippe
Hatron, Pierre Yves
Emmerich, Joseph
Cacoub, Patrice
Resche‐Rigon, Matthieu
Lambert, Marc
Saadoun, David
author_sort Le Joncour, Alexandre
collection PubMed
description BACKGROUND: Data regarding long‐term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long‐term outcome and prognostic factors in a large cohort of thromboangiitis obliterans. METHODS AND RESULTS: Retrospective multicenter study of characteristics and outcomes of 224 thromboangiitis obliterans patients fulfilling Papa's criteria were analyzed. Factors associated with vascular events and amputations were identified. The median age at diagnosis was 38.5 (32–46) years, 51 (23.8%) patients were female, and 81.7% were whites. After a mean follow‐up of 5.7 years, vascular events were observed in 58.9%, amputations in 21.4%, and death in 1.4%. The 5‐, 10‐, and 15‐year vascular event‐free survival and amputation‐free survival were 41% and 85%, 23% and 74%, and 19% and 66%, respectively. Ethnic group (nonwhite) (hazard ratio 2.35 [1.30–4.27] P=0.005) and limb infection at diagnosis (hazard ratio 3.29 [1.02–10.6] P=0.045) were independent factors of vascular event‐free survival. Factor associated with amputation was limb infection (hazard ratio 12.1 [3.5–42.1], P<0.001). Patients who stopped their tobacco consumption had lower risk of amputation (P=0.001) than those who continued. CONCLUSIONS: This nationwide study shows that 34% of thromboangiitis obliterans patients will experience an amputation within 15 years from diagnosis. We identified high‐risk patients for vascular complications and amputations.
format Online
Article
Text
id pubmed-6405548
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64055482019-03-21 Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients Le Joncour, Alexandre Soudet, Simon Dupont, Axelle Espitia, Olivier Koskas, Fabien Cluzel, Philippe Hatron, Pierre Yves Emmerich, Joseph Cacoub, Patrice Resche‐Rigon, Matthieu Lambert, Marc Saadoun, David J Am Heart Assoc Original Research BACKGROUND: Data regarding long‐term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long‐term outcome and prognostic factors in a large cohort of thromboangiitis obliterans. METHODS AND RESULTS: Retrospective multicenter study of characteristics and outcomes of 224 thromboangiitis obliterans patients fulfilling Papa's criteria were analyzed. Factors associated with vascular events and amputations were identified. The median age at diagnosis was 38.5 (32–46) years, 51 (23.8%) patients were female, and 81.7% were whites. After a mean follow‐up of 5.7 years, vascular events were observed in 58.9%, amputations in 21.4%, and death in 1.4%. The 5‐, 10‐, and 15‐year vascular event‐free survival and amputation‐free survival were 41% and 85%, 23% and 74%, and 19% and 66%, respectively. Ethnic group (nonwhite) (hazard ratio 2.35 [1.30–4.27] P=0.005) and limb infection at diagnosis (hazard ratio 3.29 [1.02–10.6] P=0.045) were independent factors of vascular event‐free survival. Factor associated with amputation was limb infection (hazard ratio 12.1 [3.5–42.1], P<0.001). Patients who stopped their tobacco consumption had lower risk of amputation (P=0.001) than those who continued. CONCLUSIONS: This nationwide study shows that 34% of thromboangiitis obliterans patients will experience an amputation within 15 years from diagnosis. We identified high‐risk patients for vascular complications and amputations. John Wiley and Sons Inc. 2018-12-01 /pmc/articles/PMC6405548/ /pubmed/30571594 http://dx.doi.org/10.1161/JAHA.118.010677 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Le Joncour, Alexandre
Soudet, Simon
Dupont, Axelle
Espitia, Olivier
Koskas, Fabien
Cluzel, Philippe
Hatron, Pierre Yves
Emmerich, Joseph
Cacoub, Patrice
Resche‐Rigon, Matthieu
Lambert, Marc
Saadoun, David
Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
title Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
title_full Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
title_fullStr Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
title_full_unstemmed Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
title_short Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
title_sort long‐term outcome and prognostic factors of complications in thromboangiitis obliterans (buerger's disease): a multicenter study of 224 patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405548/
https://www.ncbi.nlm.nih.gov/pubmed/30571594
http://dx.doi.org/10.1161/JAHA.118.010677
work_keys_str_mv AT lejoncouralexandre longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT soudetsimon longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT dupontaxelle longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT espitiaolivier longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT koskasfabien longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT cluzelphilippe longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT hatronpierreyves longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT emmerichjoseph longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT cacoubpatrice longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT rescherigonmatthieu longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT lambertmarc longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT saadoundavid longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients
AT longtermoutcomeandprognosticfactorsofcomplicationsinthromboangiitisobliteransbuergersdiseaseamulticenterstudyof224patients